Postoperative Hemodynamic Evaluation of a New Fabric-Covered Ball-Valve Prosthesis
Previous in vitro and in vivo experimental studies have indicated that insertion of the Braun-wald-Cutter fabric-covered ball-valve prosthesis results in negligible thromboembolic complications and hemodynamic performance comparable to that of noncovered mitral and aortic ball-valve prostheses. To assess the clinical efficacy of this fabric-covered valve prosthesis, 35 patients have been followed for 4 to 26 months (540 patient-months) after mitral and/or aortic valve replacement, and 13 have had extensive hemodynamic re-evaluation.
In eight patients with the mitral valve prosthesis, the mean diastolic gradient averaged 4.8 mm Hg (range 0 to 8) and the end-diastolic gradient 0.8 mm Hg (range 0 to 2) at a time when the mean heart rate was 75 beats/min (range 50 to 100) and the cardiac output averaged 5.1 L/min (range 3.4 to 8.0). The calculated effective mitral valve orifice size averaged 2.68 cm2 (range 1.92 to 3.46). In six patients with the aortic valve prosthesis, the average peak systolic gradient was 13 mm Hg (range 0 to 22), and the mean systolic gradient averaged 14.5 mm Hg (range 0 to 24) when the mean heart rate was 82 beats/min (range 64 to 120) and the cardiac output averaged 6.2 L/min (range 3.2 to 9.3). The average effective aortic valve size in the five patients with a mean systolic transvalvular gradient was 1.41 cm2 (range 1.26 to 1.62).
Only one postoperative thromboembolic complication has been observed, and this occurred in a patient with atrial fibrillation and a large left atrium three weeks after discontinuing anticoagulant therapy because of gingival bleeding.
These data indicate that use of the fabric-covered Braunwald-Cutter ball prosthesis produces few thromboembolic complications and a satisfactory hemodynamic result.
- © 1973 American Heart Association, Inc.